<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36833252</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">325</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes14020325</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is described as a fatal and rapidly progressive neurodegenerative disorder caused by the degeneration of upper motor neurons in the primary motor cortex and lower motor neurons of the brainstem and spinal cord. Due to ALS's slowly progressive characteristic, which is often accompanied by other neurological comorbidities, its diagnosis remains challenging. Perturbations in vesicle-mediated transport and autophagy as well as cell-autonomous disease initiation in glutamatergic neurons have been revealed in ALS. The use of extracellular vesicles (EVs) may be key in accessing pathologically relevant tissues for ALS, as EVs can cross the blood-brain barrier and be isolated from the blood. The number and content of EVs may provide indications of the disease pathogenesis, its stage, and prognosis. In this review, we collected a recent study aiming at the identification of EVs as a biomarker of ALS with respect to the size, quantity, and content of EVs in the biological fluids of patients compared to controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbo</LastName><ForeName>Maru&#x161;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravnik-Glava&#x10d;</LastName><ForeName>Metka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3716-4215</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36833252</ArticleId><ArticleId IdType="pmc">PMC9956314</ArticleId><ArticleId IdType="doi">10.3390/genes14020325</ArticleId><ArticleId IdType="pii">genes14020325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhasmana S., Dhasmana A., Narula A.S., Jaggi M., Yallapu M.M., Chauhan S.C. The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sci. 2021;288:120156. doi: 10.1016/j.lfs.2021.120156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.120156</ArticleId><ArticleId IdType="pubmed">34801512</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Ingre C., Roos P.M., Kamel F., Piehl F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J. Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron Diseases: An Overview. Neurodiagnostic J. 2015;55:180&#x2013;194. doi: 10.1080/21646821.2015.1075181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21646821.2015.1075181</ArticleId><ArticleId IdType="pubmed">26630810</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack S.A., Dunlop R.A., Stommel E.W., Mehta P., Cox P.A. miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis. J. Neurol. Sci. 2022;442:120396. doi: 10.1016/j.jns.2022.120396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120396</ArticleId><ArticleId IdType="pubmed">36081303</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E., Rajasekaran R. A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis. J. Mol. Neurosci. 2020;70:1742&#x2013;1770. doi: 10.1007/s12031-020-01569-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-020-01569-w</ArticleId><ArticleId IdType="pubmed">32415434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjoqvist S., Otake K. A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates. Biochem. Biophys. Res. Commun. 2022;613:166&#x2013;173. doi: 10.1016/j.bbrc.2022.04.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.04.127</ArticleId><ArticleId IdType="pubmed">35567903</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., van Broeckhoven C., van der Zee J. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Al-Chalabi A., Chio A., Hardiman O., Kiernan M.C., Rohrer J.D., Rowe J., Seeley W., Talbot K. Genetic screening in sporadic ALS and FTD. J. Neurol. Neurosurg. Psychiatry. 2017;88:1042&#x2013;1044. doi: 10.1136/jnnp-2017-315995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315995</ArticleId><ArticleId IdType="pmc">PMC5740553</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V., Bueno-De-Mesquita H.B., Vermeulen R., Andersen P.M., Kyrozis A., Linseisen J., Kaaks R., Allen N.E., Roddam A.W., Boshuizen H.C., et al. Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort. Ann. Neurol. 2009;65:378&#x2013;385. doi: 10.1002/ana.21653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21653</ArticleId><ArticleId IdType="pubmed">19399866</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M.G., McCullough M.L., Calle E.E., Thun M.J., Cudkowicz M., Ascherio A. Prospective Study of Cigarette Smoking and Amyotrophic Lateral Sclerosis. Am. J. Epidemiol. 2004;160:26&#x2013;33. doi: 10.1093/aje/kwh179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh179</ArticleId><ArticleId IdType="pubmed">15229114</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Murthy S.B., Wilson A.M., Qureshi S.U., Amro M.J., Wheaton M., Simpson E., Harati Y., Strutt A.M., York M.K., et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph. Lateral Scler. 2010;11:542&#x2013;548. doi: 10.3109/17482968.2010.482592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.482592</ArticleId><ArticleId IdType="pubmed">20500116</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Nagaoka U., Nakayama Y., Kawata A., Kugimoto C., Kuroiwa Y., Kawai M., Shimohata T., Nishizawa M., Mihara B., et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan. Amyotroph. Lateral Scler. 2012;13:363&#x2013;366. doi: 10.3109/17482968.2012.678366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.678366</ArticleId><ArticleId IdType="pubmed">22632442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman E.J., Hein M.J., Baron S.L., Gersic C.M. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970&#x2013;1974. doi: 10.1212/WNL.0b013e31826daf50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Felmus M.T., Patten B.M., Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology. 1976;26:167. doi: 10.1212/WNL.26.2.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.26.2.167</ArticleId><ArticleId IdType="pubmed">946326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., Bedlack R.S., Richards M., Watson M., Alavanja M.C., Blair A., Hoppin J.A., Schmidt S., Sandler D.P. Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology. 2012;33:457&#x2013;462. doi: 10.1016/j.neuro.2012.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2012.04.001</ArticleId><ArticleId IdType="pmc">PMC3358481</ArticleId><ArticleId IdType="pubmed">22521219</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M.G., Morozova N., O&#x2019;Reilly E.J., McCullough M.L., Calle E.E., Thun M.J., Ascherio A. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2009;80:558&#x2013;561. doi: 10.1136/jnnp.2008.156976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.156976</ArticleId><ArticleId IdType="pmc">PMC2765376</ArticleId><ArticleId IdType="pubmed">19372290</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R., Liu J., Rothstein J., Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann. Neurol. 2010;69:141&#x2013;151. doi: 10.1002/ana.22149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfahad T., Nath A. Retroviruses and amyotrophic lateral sclerosis. Antivir. Res. 2013;99:180&#x2013;187. doi: 10.1016/j.antiviral.2013.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.05.006</ArticleId><ArticleId IdType="pmc">PMC3723705</ArticleId><ArticleId IdType="pubmed">23707220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Weisskopf M.G., O&#x2019;Reilly E.J., Jacobs E.J., McCullough M.L., Calle E.E., Cudkowicz M., Thun M.J. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann. Neurol. 2004;57:104&#x2013;110. doi: 10.1002/ana.20316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20316</ArticleId><ArticleId IdType="pubmed">15529299</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar U.G., Milla V., Cynthia Stafford M.Y., Bjourson A.J., Duddy W., Duguez S.M.-R. A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Front. Neurol. 2019;10:400. doi: 10.3389/fneur.2019.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00400</ArticleId><ArticleId IdType="pmc">PMC6527847</ArticleId><ArticleId IdType="pubmed">31139131</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2013;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Mavel S., Corcia P., Gordon P. The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development. Curr. Med. Chem. 2014;21:3551&#x2013;3575. doi: 10.2174/0929867321666140916120118.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867321666140916120118</ArticleId><ArticleId IdType="pubmed">25245510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004;10:S10&#x2013;S17. doi: 10.1038/nm1066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. Prion-like Mechanism in Amyotrophic Lateral Sclerosis: Are Protein Aggregates the Key. Exp. Neurobiol. 2015;24:1&#x2013;7. doi: 10.5607/en.2015.24.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId><ArticleId IdType="pmc">PMC4363329</ArticleId><ArticleId IdType="pubmed">25792864</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.-F., Kabashi E., Desnuelle C. Deciphering spreading mechanisms in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2015;28:455&#x2013;461. doi: 10.1097/WCO.0000000000000239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000239</ArticleId><ArticleId IdType="pubmed">26356410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella E.D., Bersano E., Antonini G., Borghero G., Capasso M., Caponnetto C., Chi&#xf2; A., Corbo M., Filosto M., Giannini F., et al. The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial. Brain. 2021;144:2635&#x2013;2647. doi: 10.1093/brain/awab167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab167</ArticleId><ArticleId IdType="pmc">PMC8557337</ArticleId><ArticleId IdType="pubmed">33905493</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Bassot A., Giuliani F., Simmen T. Amyotrophic Lateral Sclerosis (ALS): Stressed by Dysfunctional Mitochondria-Endoplasmic Reticulum Contacts (MERCs) Cells. 2021;10:1789. doi: 10.3390/cells10071789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071789</ArticleId><ArticleId IdType="pmc">PMC8304209</ArticleId><ArticleId IdType="pubmed">34359958</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S., Valenzuela V., Medinas D.B., Hetz C. ER Dysfunction and Protein Folding Stress in ALS. Int. J. Cell Biol. 2013;2013:674751. doi: 10.1155/2013/674751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/674751</ArticleId><ArticleId IdType="pmc">PMC3845333</ArticleId><ArticleId IdType="pubmed">24324498</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Barbagallo P., Talbot K. The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS. Front. Cell. Neurosci. 2021;15:653688. doi: 10.3389/fncel.2021.653688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.653688</ArticleId><ArticleId IdType="pmc">PMC8047135</ArticleId><ArticleId IdType="pubmed">33867942</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Zhang X., Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy. 2008;4:290&#x2013;293. doi: 10.4161/auto.5524.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5524</ArticleId><ArticleId IdType="pubmed">18196963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua J.P., de Calbiac H., Kabashi E., Barmada S.J. Autophagy and ALS: Mechanistic insights and therapeutic implications. Autophagy. 2021;18:254&#x2013;282. doi: 10.1080/15548627.2021.1926656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1926656</ArticleId><ArticleId IdType="pmc">PMC8942428</ArticleId><ArticleId IdType="pubmed">34057020</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F., Morimoto N., Liu W., Ohta Y., Deguchi K., Miyazaki K., Abe K. In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:985&#x2013;992. doi: 10.4161/auto.7.9.16012.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.9.16012</ArticleId><ArticleId IdType="pubmed">21628996</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N., Nagai M., Ohta Y., Miyazaki K., Kurata T., Morimoto M., Murakami T., Takehisa Y., Ikeda Y., Kamiya T., et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112&#x2013;117. doi: 10.1016/j.brainres.2007.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.06.045</ArticleId><ArticleId IdType="pubmed">17689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Komine O., Yamanaka K. Neuroinflammation in motor neuron disease. Nagoya J. Med. Sci. 2015;77:537&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664586</ArticleId><ArticleId IdType="pubmed">26663933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S., Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2015;1852:679&#x2013;684. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Delic V., Kurien C., Cruz J., Zivkovic S., Barretta J., Thomson A., Hennessey D., Joseph J., Ehrhart J., Willing A.E., et al. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients. J. Neurosci. Res. 2018;96:1353&#x2013;1366. doi: 10.1002/jnr.24249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24249</ArticleId><ArticleId IdType="pubmed">29732581</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand A., Thakur K., Gupta P.K. ALS and Oxidative Stress: The Neurovascular Scenario. Oxidative Med. Cell. Longev. 2013;2013:635831. doi: 10.1155/2013/635831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/635831</ArticleId><ArticleId IdType="pmc">PMC3866720</ArticleId><ArticleId IdType="pubmed">24367722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Varghese A.M., Vijaylakshmi K., Sumitha R., Prasanna V.K., Shruthi S., Sagar B.K.C., Datta K.K., Gowda H., Nalini A., et al. Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction. Neurochem. Res. 2015;41:965&#x2013;984. doi: 10.1007/s11064-015-1779-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1779-7</ArticleId><ArticleId IdType="pubmed">26646005</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:1&#x2013;14. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M.C., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., Gage F.H. Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Boulting G.L., Bobrowicz S., Eggan K.C. Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation. Cell Stem Cell. 2008;3:637&#x2013;648. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M., Pozzi S., Tortarolo M., Fiordaliso F., Bisighini C., Pasetto L., Spaltro G., Lidonnici D., Gensano F., Battaglia E., et al. Mutant Copper-Zinc Superoxide Dismutase (SOD1) Induces Protein Secretion Pathway Alterations and Exosome Release in Astrocytes. J. Biol. Chem. 2013;288:15699&#x2013;15711. doi: 10.1074/jbc.M112.425066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.425066</ArticleId><ArticleId IdType="pmc">PMC3668729</ArticleId><ArticleId IdType="pubmed">23592792</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Martin L.J., Kuncl R.W. Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 1992;326:1464&#x2013;1468. doi: 10.1056/NEJM199205283262204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199205283262204</ArticleId><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek R.A.A., V&#xf5;sa U., de Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch F., Fenouil R., Gut M., Cauchy P., Albert T.K., Zacarias-Cabeza J., Spicuglia S., de la Chapelle A.L., Heidemann M., Hintermair C., et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat. Struct. Mol. Biol. 2011;18:956&#x2013;963. doi: 10.1038/nsmb.2085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2085</ArticleId><ArticleId IdType="pubmed">21765417</ArticleId></ArticleIdList></Reference><Reference><Citation>Graur D. An Upper Limit on the Functional Fraction of the Human Genome. Genome Biol. Evol. 2017;9:1880&#x2013;1885. doi: 10.1093/gbe/evx121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gbe/evx121</ArticleId><ArticleId IdType="pmc">PMC5570035</ArticleId><ArticleId IdType="pubmed">28854598</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Zhang S., Kenna K.P., Moll T., Franklin J.P., Allen S., Nezhad H.G., Iacoangeli A., Yacovzada N.Y., Eitan C., et al. Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene. Cell Rep. 2020;33:108456. doi: 10.1016/j.celrep.2020.108456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108456</ArticleId><ArticleId IdType="pmc">PMC7710676</ArticleId><ArticleId IdType="pubmed">33264630</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida A., Takahashi A., Kubo M., Saito S., Hosono N., Ohnishi Y., Kiyotani K., Mushiroda T., Nakajima M., Ozaki K., et al. A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum. Mol. Genet. 2011;20:3684&#x2013;3692. doi: 10.1093/hmg/ddr268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr268</ArticleId><ArticleId IdType="pubmed">21665992</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrizaila N., Sobue G., Kuwabara S., Kim S.H., Birks C., Fan D.S., Bae J.S., Hu C.J., Gourie-Devi M., Noto Y., et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J. Neurol. Neurosurg. Psychiatry. 2016;87:821&#x2013;830. doi: 10.1136/jnnp-2015-312751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312751</ArticleId><ArticleId IdType="pubmed">27093948</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards D., Morren J.A., Pioro E.P. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J. Neurol. Sci. 2020;417:117054. doi: 10.1016/j.jns.2020.117054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117054</ArticleId><ArticleId IdType="pubmed">32763509</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika R.H., Siah W.F., McKenna M.C., Shing S.L.H., Hardiman O., Bede P. The presymptomatic phase of amyotrophic lateral sclerosis: Are we merely scratching the surface. J. Neurol. 2020;268:4607&#x2013;4629. doi: 10.1007/s00415-020-10289-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10289-5</ArticleId><ArticleId IdType="pubmed">33130950</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., Bede P., El Mendili M.M., Li M., P&#xe9;l&#xe9;grini-Issac M., Rinaldi D., Catala M., Saracino D., Salachas F., Camuzat A., et al. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study. Ann. Neurol. 2019;86:158&#x2013;167. doi: 10.1002/ana.25520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25520</ArticleId><ArticleId IdType="pubmed">31177556</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M. Electrodiagnosis of Amyotrophic Lateral Sclerosis: A Review of Existing Guidelines. J. Clin. Neurophysiol. 2020;37:294&#x2013;298. doi: 10.1097/WNP.0000000000000682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNP.0000000000000682</ArticleId><ArticleId IdType="pubmed">33151660</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#x11b;tk&#xe1;&#x159;ov&#xe1; I., Ehler E. Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date. Diagnostics. 2021;11:231. doi: 10.3390/diagnostics11020231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020231</ArticleId><ArticleId IdType="pmc">PMC7913557</ArticleId><ArticleId IdType="pubmed">33546386</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N.S., Shepheard S.R., Sassani M., McDonough H.E., Moore S.A., Alix J.J.P., Wilkinson I.D., Jenkins T.M., Shaw P.J. Biomarkers in Motor Neuron Disease: A State of the Art Review. Front. Neurol. 2019;10:291. doi: 10.3389/fneur.2019.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Desport J.C., Kajeu P., Jesus P., Nicolaud B., Nicol M., Preux P.M., Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry. 2010;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Shen D., Tai H., Cui L. Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis. Front. Aging Neurosci. 2016;8:290. doi: 10.3389/fnagi.2016.00290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00290</ArticleId><ArticleId IdType="pmc">PMC5126108</ArticleId><ArticleId IdType="pubmed">27965574</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Feneberg E., Weishaupt J., Brettschneider J., Tumani H., Andersen P.M., von Arnim C.A.F., B&#xf6;hm S., Kassubek J., Kubisch C., et al. Neurofilaments in the diagnosis of motoneuron diseases: A prospective study on 455 patients. J. Neurol. Neurosurg. Psychiatry. 2015;87:12&#x2013;20. doi: 10.1136/jnnp-2015-311387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311387</ArticleId><ArticleId IdType="pubmed">26296871</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., de Schaepdryver M., Stubendorff B., Gille B., Muckova P., Wendler S., Prell T., Ringer T.M., Rhode H., Stevens O., et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88:2302&#x2013;2309. doi: 10.1212/WNL.0000000000004029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004029</ArticleId><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Jardel C., Salachas F., Lamari F., Andersen P.M., Bowser R., de Carvalho M., Costa J., Van Damme P., Gray E., et al. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph. Lateral Scler. Front. Degener. 2016;17:404&#x2013;413. doi: 10.3109/21678421.2016.1167913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1167913</ArticleId><ArticleId IdType="pubmed">27415180</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D., Volanti P., Brambilla L., Colletti T., Spataro R., La Bella V. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J. Neurol. 2018;265:510&#x2013;521. doi: 10.1007/s00415-017-8730-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8730-6</ArticleId><ArticleId IdType="pubmed">29322259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.-S., Lee W.-J., Wang S.-J., Fuh J.-L. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. Sci. Rep. 2018;8:17368. doi: 10.1038/s41598-018-35766-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35766-w</ArticleId><ArticleId IdType="pmc">PMC6255914</ArticleId><ArticleId IdType="pubmed">30478269</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinhofer I., Rommer P., Zierfuss B., Altmann P., Foiani M., Heslegrave A., Zetterberg H., Gleiss A., Musolino P.L., Gong Y., et al. Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nat. Commun. 2021;12:1&#x2013;10. doi: 10.1038/s41467-021-22114-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22114-2</ArticleId><ArticleId IdType="pmc">PMC7985512</ArticleId><ArticleId IdType="pubmed">33753741</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinomoto M., Kasai T., Tatebe H., Kondo M., Ohmichi T., Morimoto M., Chiyonobu T., Terada N., Allsop D., Yokota I., et al. Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients. PLoS ONE. 2019;14:e0211575. doi: 10.1371/journal.pone.0211575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211575</ArticleId><ArticleId IdType="pmc">PMC6450630</ArticleId><ArticleId IdType="pubmed">30951523</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M.A., An J., Hood B.L., Conrads T.P., Bowser R.P. Label-Free LC&#x2013;MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. J. Proteome Res. 2015;14:4486&#x2013;4501. doi: 10.1021/acs.jproteome.5b00804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00804</ArticleId><ArticleId IdType="pmc">PMC5592736</ArticleId><ArticleId IdType="pubmed">26401960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005;95:1461&#x2013;1471. doi: 10.1111/j.1471-4159.2005.03478.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03478.x</ArticleId><ArticleId IdType="pmc">PMC1540444</ArticleId><ArticleId IdType="pubmed">16313519</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H., An J., Darko S., Lustgarten J.L., Jaffa M., Gopalakrishnan V., Lacomis D., Cudkowicz M.E., Bowser R. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42:104&#x2013;111. doi: 10.1002/mus.21683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21683</ArticleId><ArticleId IdType="pmc">PMC2975276</ArticleId><ArticleId IdType="pubmed">20583124</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese A.M., Sharma A., Mishra P., Vijayalakshmi K., Harsha H.C., Sathyaprabha T.N., Bharath S.M., Nalini A., Alladi P.A., Raju T.R. Chitotriosidase&#x2014;A putative biomarker for sporadic amyotrophic lateral sclerosis. Clin. Proteom. 2013;10:19. doi: 10.1186/1559-0275-10-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1559-0275-10-19</ArticleId><ArticleId IdType="pmc">PMC4220794</ArticleId><ArticleId IdType="pubmed">24295388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu X.-H., Wu J.-J., Ren H.-M., Wang J., Ding Z.-T., Jiang Y.-P. Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis. Exp. Ther. Med. 2016;11:2095&#x2013;2106. doi: 10.3892/etm.2016.3210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3210</ArticleId><ArticleId IdType="pmc">PMC4887813</ArticleId><ArticleId IdType="pubmed">27284291</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Corcia P., Moreau C., Veau S., Fournier C., Vourc&#x2019;H P., Emond P., Gordon P., Pradat P.-F., Praline J., et al. 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis. PLoS ONE. 2010;5:e13223. doi: 10.1371/annotation/2c2f8fce-a5be-40a3-af8f-48f119b2c593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/2c2f8fce-a5be-40a3-af8f-48f119b2c593</ArticleId><ArticleId IdType="pmc">PMC2951909</ArticleId><ArticleId IdType="pubmed">20949041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A., Jonsson P., Ahnlund M., Antti H., Marklund S.L., Moritz T., Forsgren L., Andersen P.M., Trupp M. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson&#x2019;s disease and control subjects. Mol. Biosyst. 2016;12:1287&#x2013;1298. doi: 10.1039/C5MB00711A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5MB00711A</ArticleId><ArticleId IdType="pubmed">26883206</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J., Yutuc E., Crick P.J., Gustafsson J., Warner M., Roman G., Talbot K., Gray E., Griffiths W.J., Turner M.R., et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Patin F., Molinier S., Vourc&#x2019;H P., Le Tilly O., Bakkouche S., Andres C., Meininger V., Couratier P., Corcia P. A decrease in blood cholesterol after gastrostomy could impact survival in ALS. Eur. J. Clin. Nutr. 2017;71:1133&#x2013;1135. doi: 10.1038/ejcn.2017.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2017.54</ArticleId><ArticleId IdType="pubmed">28422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentino F., Bivona G., Butera D., Paladino P., Fazzari M., Piccoli T., Ciaccio M., La Bella V. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS. Eur. J. Neurol. 2010;17:84&#x2013;89. doi: 10.1111/j.1468-1331.2009.02752.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02752.x</ArticleId><ArticleId IdType="pubmed">19659753</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell R.M., Freeman W.M., Randazzo W.T., Stephens H.E., Beard J.L., Simmons Z., Connor J.R. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2008;72:14&#x2013;19. doi: 10.1212/01.wnl.0000333251.36681.a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000333251.36681.a5</ArticleId><ArticleId IdType="pubmed">18987350</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Yang X., Gao L., Zang D. Evaluating the levels of CSF and serum factors in ALS. Brain Behav. 2017;7:e00637. doi: 10.1002/brb3.637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.637</ArticleId><ArticleId IdType="pmc">PMC5346523</ArticleId><ArticleId IdType="pubmed">28293476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind A.-L., Wu D., Freyhult E., Bodolea C., Ekegren T., Larsson A., Gustafsson M.G., Katila L., Bergquist J., Gordh T., et al. A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients. PLoS ONE. 2016;11:e0149821. doi: 10.1371/journal.pone.0149821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0149821</ArticleId><ArticleId IdType="pmc">PMC4767403</ArticleId><ArticleId IdType="pubmed">26914813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrhart J., Smith A.J., Kuzmin-Nichols N., Zesiewicz T.A., Jahan I., Shytle R.D., Kim S.-H., Sanberg C.D., Vu T.H., Gooch C.L., et al. Humoral factors in ALS patients during disease progression. J. Neuroinflamm. 2015;12:1&#x2013;11. doi: 10.1186/s12974-015-0350-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0350-4</ArticleId><ArticleId IdType="pmc">PMC4487852</ArticleId><ArticleId IdType="pubmed">26126965</ArticleId></ArticleIdList></Reference><Reference><Citation>Winer L., Srinivasan D., Chun S., Lacomis D., Jaffa M., Fagan A., Holtzman D.M., Wancewicz E., Bennett C.F., Bowser R., et al. SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy. JAMA Neurol. 2013;70:201&#x2013;207. doi: 10.1001/jamaneurol.2013.593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.593</ArticleId><ArticleId IdType="pmc">PMC3812918</ArticleId><ArticleId IdType="pubmed">23147550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m P., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Marklund S.L. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J. Neurochem. 2011;117:91&#x2013;99. doi: 10.1111/j.1471-4159.2011.07177.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07177.x</ArticleId><ArticleId IdType="pubmed">21226712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Garofalo D.C., Santella R.M., Sorenson E.J., Oskarsson B., Americo F.J.M., Jr., Andrews H., Hupf J., Gilmore M., Heitzman D., et al. Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2020;21:263&#x2013;272. doi: 10.1080/21678421.2020.1746810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1746810</ArticleId><ArticleId IdType="pmc">PMC7373369</ArticleId><ArticleId IdType="pubmed">32276554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M., Brown R.H., Matson W., Smart R., Hayden D., O&#x2019;Donnell H., Beal M.F., Cudkowicz M. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 2000;29:652&#x2013;658. doi: 10.1016/S0891-5849(00)00349-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00349-X</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M.F., Ferrante R.J., Browne S.E., Matthew R.T., Kowall N.W., Brown R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 1997;42:644&#x2013;654. doi: 10.1002/ana.410420416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420416</ArticleId><ArticleId IdType="pubmed">9382477</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Highley R., Dickman M., Edbauer D., Ince P.G., Wharton S.B., Wilson S., Kirby J., et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Chew J., Stankowski J.N., Hayes L.R., Zhang Y.-J., Prudencio M., Carlomagno Y., Daughrity L.M., Jansen-West K., Perkerson E.A., et al. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:383. doi: 10.1126/scitranslmed.aai7866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aai7866</ArticleId><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Ludolph A.C., Weishaupt J.H. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>de Felice B., Annunziata A., Fiorentino G., Borra M., Biffali E., Coppola C., Cotrufo R., Brettschneider J., Giordana M.L., Dalmay T., et al. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics. 2014;15:243&#x2013;253. doi: 10.1007/s10048-014-0420-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0420-2</ArticleId><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M., Ricci C., Jones A.R., Giannini F., Al-Chalabi A., Battistini S. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. Neuromol. Med. 2016;18:551&#x2013;560. doi: 10.1007/s12017-016-8396-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-016-8396-8</ArticleId><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange D.J., Andersen P.M., Remanan R., Marklund S., Benjamin D. Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: A phase I pilot study. Amyotroph. Lateral Scler. Front. Degener. 2012;14:199&#x2013;204. doi: 10.3109/17482968.2012.724074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.724074</ArticleId><ArticleId IdType="pubmed">22985433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong M.-L., Tan P.F., Holbrook J.D. Predicting functional decline and survival in amyotrophic lateral sclerosis. PLoS ONE. 2017;12:e0174925. doi: 10.1371/journal.pone.0174925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174925</ArticleId><ArticleId IdType="pmc">PMC5390993</ArticleId><ArticleId IdType="pubmed">28406915</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D., Hammar N., Malmstr&#xf6;m H., Ingre C., Jungner I., Ye W., Fang F., Walldius G. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton K.A., Brown M.V., Alexander D., Li Z., Wulff J.E., Lawson R., Jaffa M., Milburn M.V., Ryals J.A., Bowser R., et al. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph. Lateral Scler. Front. Degener. 2014;15:362&#x2013;370. doi: 10.3109/21678421.2014.908311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.908311</ArticleId><ArticleId IdType="pubmed">24984169</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchi M., Messina P., Airoldi L., Pupillo E., Di Poggio M.B., Calvo A., Filosto M., Lunetta C., Mandrioli J., Pisa F., et al. Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2014;15:371&#x2013;375. doi: 10.3109/21678421.2014.920032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.920032</ArticleId><ArticleId IdType="pubmed">24904978</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadou E., Kapaki E., Kokotis P., Paraskevas G.P., Katsaros N., Libitaki G., Zis V., Sfagos C., Vassilopoulos D. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment. Clin. Neurol. Neurosurg. 2008;110:222&#x2013;226. doi: 10.1016/j.clineuro.2007.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2007.10.018</ArticleId><ArticleId IdType="pubmed">18055102</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I., Janik P., Kwieci&#x144;ski H. Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2002;106:39&#x2013;43. doi: 10.1034/j.1600-0404.2002.00206.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2002.00206.x</ArticleId><ArticleId IdType="pubmed">12067327</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Nicholson K., Chan J., Shui A., Schoenfeld D., Sherman A., Berry J., Cudkowicz M., Atassi N., for the Pooled Resource Open-Access ALS Clinical Trials Consortium Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database. Muscle Nerve. 2017;57:430&#x2013;434. doi: 10.1002/mus.25950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25950</ArticleId><ArticleId IdType="pmc">PMC5812805</ArticleId><ArticleId IdType="pubmed">28857199</ArticleId></ArticleIdList></Reference><Reference><Citation>Patin F., Corcia P., Hounoum B.M., Veyrat-Durebex C., Respaud E., Piver E., Bretagne I.B.-D., Vourc&#x2019;H P., Andres C.R., Blasco H. Biological follow-up in amyotrophic lateral sclerosis: Decrease in creatinine levels and increase in ferritin levels predict poor prognosis. Eur. J. Neurol. 2015;22:1385&#x2013;1390. doi: 10.1111/ene.12754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12754</ArticleId><ArticleId IdType="pubmed">26095828</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X.W., Clardy S.L., Stephens H.E., Simmons Z., Connor J.R. Serum ferritin is elevated in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Front. Degener. 2014;16:102&#x2013;107. doi: 10.3109/21678421.2014.984723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.984723</ArticleId><ArticleId IdType="pubmed">25521651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S., Imai T., Matsubara S., Takahashi K., Jinnai K., Yamano T., Shimizu N. Decreased urinary concentrations of type IV collagen in amyotrophic lateral sclerosis. Acta Neurol. Scand. 2009;100:111&#x2013;116. doi: 10.1111/j.1600-0404.1999.tb01048.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb01048.x</ArticleId><ArticleId IdType="pubmed">10442453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S., Shimizu N., Imai T., Rodriguez G.P. Urinary collagen metabolite excretion in amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:821&#x2013;825. doi: 10.1002/mus.1075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.1075</ArticleId><ArticleId IdType="pubmed">11360267</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard S.R., Wuu J., Cardoso M., Wiklendt L., Dinning P.G., Chataway T., Schultz D., Benatar M., Rogers M.-L. Urinary p75ECD. Neurology. 2017;88:1137&#x2013;1143. doi: 10.1212/WNL.0000000000003741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003741</ArticleId><ArticleId IdType="pmc">PMC5373786</ArticleId><ArticleId IdType="pubmed">28228570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Li X., Du X., Liu S., Xu Y. Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases. Front. Aging Neurosci. 2021;13:790863. doi: 10.3389/fnagi.2021.790863.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.790863</ArticleId><ArticleId IdType="pmc">PMC8717921</ArticleId><ArticleId IdType="pubmed">34975460</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Lehrich B.M., Zheng S., Lu M. Emerging methods in biomarker identification for extracellular vesicle-based liquid biopsy. J. Extracell. Vesicles. 2021;10:e12090. doi: 10.1002/jev2.12090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12090</ArticleId><ArticleId IdType="pmc">PMC8114032</ArticleId><ArticleId IdType="pubmed">34012517</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukouris S., Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteom.&#x2013;Clin. Appl. 2015;9:358&#x2013;367. doi: 10.1002/prca.201400114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201400114</ArticleId><ArticleId IdType="pmc">PMC5502131</ArticleId><ArticleId IdType="pubmed">25684126</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Witwer K.W., Aikawa E., Alcaraz M.J., Anderson J.D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin-Smith G.K., et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachau A.C., Land&#xe9;n M., Mobarrez F., Nybom R., Wall&#xe9;n H., Wetterberg L. Leukocyte-derived microparticles and scanning electron microscopic structures in two fractions of fresh cerebrospinal fluid in amyotrophic lateral sclerosis: A case report. J. Med. Case Rep. 2012;6:274. doi: 10.1186/1752-1947-6-274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-1947-6-274</ArticleId><ArticleId IdType="pmc">PMC3492039</ArticleId><ArticleId IdType="pubmed">22943439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., La Salvia S., Colombo F., Zucca S., Pansarasa O., Diamanti L., Costa A., Lova L., Giannini M., Gagliardi S., et al. Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients. Front. Neurosci. 2019;13:344. doi: 10.3389/fnins.2019.00344.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00344</ArticleId><ArticleId IdType="pmc">PMC6476347</ArticleId><ArticleId IdType="pubmed">31037054</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., La Salvia S., Giannini M., Crippa V., Gagliardi S., Bernuzzi S., Diamanti L., Ceroni M., Pansarasa O., Poletti A., et al. Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients. Front. Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson A.G., Gray E., M&#xe4;ger I., Th&#xe9;z&#xe9;nas M.-L., Charles P.D., Talbot K., Fischer R., Kessler B.M., Wood M., Turner M.R. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clin. Proteom. 2020;17:1&#x2013;12. doi: 10.1186/s12014-020-09294-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-020-09294-7</ArticleId><ArticleId IdType="pmc">PMC7433176</ArticleId><ArticleId IdType="pubmed">32821252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo T.-W., Figueroa-Romero C., Hur J., Pacut C., Stoll E., Spring C., Lewis R., Nair A., Goutman S.A., Sakowski S.A., et al. Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2021;14:739016. doi: 10.3389/fnmol.2021.739016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.739016</ArticleId><ArticleId IdType="pmc">PMC8586523</ArticleId><ArticleId IdType="pubmed">34776863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Chen X., Yang Y. Pathogenic Extracellular Vesicle (EV) Signaling in Amyotrophic Lateral Sclerosis (ALS) Neurotherapeutics. 2022;19:1119&#x2013;1132. doi: 10.1007/s13311-022-01232-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01232-9</ArticleId><ArticleId IdType="pmc">PMC9587178</ArticleId><ArticleId IdType="pubmed">35426061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Takei Y.-I., Ohara S., Fujiwara N., Hozumi I., Furukawa Y. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. Mol. Neurodegener. 2019;14:1&#x2013;21. doi: 10.1186/s13024-019-0341-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0341-5</ArticleId><ArticleId IdType="pmc">PMC6862823</ArticleId><ArticleId IdType="pubmed">31744522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Ma M., Teng J., Teng R.K., Zhou S., Yin J., Fonkem E., Huang J.H., Wu E., Wang X. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget. 2015;6:24178&#x2013;24191. doi: 10.18632/oncotarget.4680.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4680</ArticleId><ArticleId IdType="pmc">PMC4695178</ArticleId><ArticleId IdType="pubmed">26172304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N., Doi H., Kurata Y., Kagawa H., Atobe Y., Funakoshi K., Tada M., Katsumoto A., Tanaka K., Kunii M., et al. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurosci. Res. 2019;160:43&#x2013;49. doi: 10.1016/j.neures.2019.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2019.10.010</ArticleId><ArticleId IdType="pubmed">31669371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelick J., Men Y., Jin S., Seo S., Espejo-Porras F., Yang Y. Elevated exosomal secretion of miR-124-3p from spinal neurons positively associates with disease severity in ALS. Exp. Neurol. 2020;333:113414. doi: 10.1016/j.expneurol.2020.113414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113414</ArticleId><ArticleId IdType="pmc">PMC7502520</ArticleId><ArticleId IdType="pubmed">32712030</ArticleId></ArticleIdList></Reference><Reference><Citation>Caby M.-P., Lankar D., Vincendeau-Scherrer C., Raposo G., Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 2005;17:879&#x2013;887. doi: 10.1093/intimm/dxh267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxh267</ArticleId><ArticleId IdType="pubmed">15908444</ArticleId></ArticleIdList></Reference><Reference><Citation>Shet A., Aras O., Gupta K., Hass M.J., Rausch D.J., Saba N., Koopmeiners L., Key N.S., Hebbel R.P. Sickle blood contains tissue factor&#x2013;positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678&#x2013;2683. doi: 10.1182/blood-2003-03-0693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-03-0693</ArticleId><ArticleId IdType="pubmed">12805058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen M.H., Beck-Nielsen H., Andersen M.N., Handberg A. A flow cytometric method for characterization of circulating cell-derived microparticles in plasma. J. Extracell. Vesicles. 2014;3 doi: 10.3402/jev.v3.20795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.20795</ArticleId><ArticleId IdType="pmc">PMC3916676</ArticleId><ArticleId IdType="pubmed">24511371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara D., Pasetto L., Bonetto V., Basso M. Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis. Front. Neurosci. 2018;12:574. doi: 10.3389/fnins.2018.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00574</ArticleId><ArticleId IdType="pmc">PMC6107782</ArticleId><ArticleId IdType="pubmed">30174585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustapic M., Eitan E., Werner J.K., Jr., Berkowitz S.T., Lazaropoulos M.P., Tran J., Goetzl E.J., Kapogiannis D. Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes. Front. Neurosci. 2017;11:278. doi: 10.3389/fnins.2017.00278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00278</ArticleId><ArticleId IdType="pmc">PMC5439289</ArticleId><ArticleId IdType="pubmed">28588440</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M., Hama Y., Utsumi J., Takashina K., Yasumatsu H., Mori F., Wakabayashi K., Shoji M., Sasaki H. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2019;708:134176. doi: 10.1016/j.neulet.2019.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.048</ArticleId><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman M., Ter-Ovanesyan D., Trieu W., Lazarovits R., Kowal E.J.K., Lee J.H., Chen-Plotkin A.S., Regev A., Church G.M., Walt D.R. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat. Methods. 2021;18:631&#x2013;634. doi: 10.1038/s41592-021-01174-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01174-8</ArticleId><ArticleId IdType="pmc">PMC9075416</ArticleId><ArticleId IdType="pubmed">34092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xia K., Chen L., Fan D. Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients. Front. Neurosci. 2019;13:574. doi: 10.3389/fnins.2019.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00574</ArticleId><ArticleId IdType="pmc">PMC6560167</ArticleId><ArticleId IdType="pubmed">31231184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasetto L., Callegaro S., Corbelli A., Fiordaliso F., Ferrara D., Brunelli L., Sestito G., Pastorelli R., Bianchi E., Cretich M., et al. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis. Mol. Neurodegener. 2021;16:1&#x2013;21. doi: 10.1186/s13024-021-00470-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00470-3</ArticleId><ArticleId IdType="pmc">PMC8353748</ArticleId><ArticleId IdType="pubmed">34376243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.-C., Wu D., Hu C.-J., Chen H.-Y., Hsieh Y.-C., Huang C.-C. Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study. J. Neurol. Sci. 2020;418:117070. doi: 10.1016/j.jns.2020.117070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117070</ArticleId><ArticleId IdType="pubmed">32836016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., He L., Hu J., Gao Y., Shen D., Ni Y., Qin Y., Liang H., Liu J., Le W., et al. Increased expression of coronin-1a in amyotrophic lateral sclerosis: A potential diagnostic biomarker and therapeutic target. Front. Med. 2022;16:723&#x2013;735. doi: 10.1007/s11684-021-0905-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-021-0905-y</ArticleId><ArticleId IdType="pubmed">35648369</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya R., Zingg W., Shetty S., Shetty A.K. Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J. Control. Release. 2020;323:225&#x2013;239. doi: 10.1016/j.jconrel.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7299747</ArticleId><ArticleId IdType="pubmed">32289328</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Zhao Y., Zhou X., Luan J., Cui Y., Han J. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable Rare Dis. Res. 2018;7:13&#x2013;18. doi: 10.5582/irdr.2017.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack S.A., Dunlop R.A., Cox P.A. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: Towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease. Open Biol. 2020;10:200116. doi: 10.1098/rsob.200116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200116</ArticleId><ArticleId IdType="pmc">PMC7333885</ArticleId><ArticleId IdType="pubmed">32574550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pregnolato F., Cova L., Doretti A., Bardelli D., Silani V., Bossolasco P. Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study. Biomolecules. 2021;11:1220. doi: 10.3390/biom11081220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081220</ArticleId><ArticleId IdType="pmc">PMC8394507</ArticleId><ArticleId IdType="pubmed">34439885</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D., Wajnberg G., Roy J., Beauregard A.-P., Chacko S., Crapoulet N., Fournier S., Ghosh A., Lewis S., Marrero A., et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2018;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., Gagliardi S., Zucca S., Arigoni M., Giannini M., Garofalo M., Olivero M., Dell&#x2019;Orco M., Pansarasa O., Bernuzzi S., et al. Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:2737. doi: 10.3390/ijms22052737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052737</ArticleId><ArticleId IdType="pmc">PMC7962970</ArticleId><ArticleId IdType="pubmed">33800495</ArticleId></ArticleIdList></Reference><Reference><Citation>Otake K., Kamiguchi H., Hirozane Y. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. BMC Med. Genom. 2019;12:1&#x2013;11. doi: 10.1186/s12920-019-0473-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-019-0473-z</ArticleId><ArticleId IdType="pmc">PMC6329125</ArticleId><ArticleId IdType="pubmed">30630471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., Gagliardi S., Zucca S., Arigoni M., Giannini M., Garofalo M., Fantini V., Pansarasa O., Avenali M., Ramusino M.C., et al. Extracellular Vesicles Derived from Plasma of Patients with Neurodegenerative Disease Have Common Transcriptomic Profiling. Front. Aging Neurosci. 2022;14:785741. doi: 10.3389/fnagi.2022.785741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.785741</ArticleId><ArticleId IdType="pmc">PMC8889100</ArticleId><ArticleId IdType="pubmed">35250537</ArticleId></ArticleIdList></Reference><Reference><Citation>Morasso C.F., Sproviero D., Mimmi M.C., Giannini M., Gagliardi S., Vanna R., Diamanti L., Bernuzzi S., Piccotti F., Truffi M., et al. Raman spectroscopy reveals biochemical differences in plasma derived extracellular vesicles from sporadic Amyotrophic Lateral Sclerosis patients. Nanomed. Nanotechnol. Biol. Med. 2020;29:102249. doi: 10.1016/j.nano.2020.102249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nano.2020.102249</ArticleId><ArticleId IdType="pubmed">32599162</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K., Breyne K., Ughetto S., Laurent L.C., Breakefield X.O. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat. Rev. Mol. Cell Biol. 2020;21:585&#x2013;606. doi: 10.1038/s41580-020-0251-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0251-y</ArticleId><ArticleId IdType="pmc">PMC7249041</ArticleId><ArticleId IdType="pubmed">32457507</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E., Lee A., Murphy A., Chang J., Zipf A., Cudkowicz M., Atassi N. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) Amyotroph. Lateral Scler. Front. Degener. 2014;15:453&#x2013;456. doi: 10.3109/21678421.2014.903974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.903974</ArticleId><ArticleId IdType="pmc">PMC4433003</ArticleId><ArticleId IdType="pubmed">24981792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D., Bresolin N., Comi G.P., Corti S. Extracellular vesicles and amyotrophic lateral sclerosis: From misfolded protein vehicles to promising clinical biomarkers. Cell. Mol. Life Sci. 2020;78:561&#x2013;572. doi: 10.1007/s00018-020-03619-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03619-3</ArticleId><ArticleId IdType="pmc">PMC7872995</ArticleId><ArticleId IdType="pubmed">32803397</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M., Bonetto V. Extracellular Vesicles and a Novel Form of Communication in the Brain. Front. Neurosci. 2016;10:127. doi: 10.3389/fnins.2016.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00127</ArticleId><ArticleId IdType="pmc">PMC4814526</ArticleId><ArticleId IdType="pubmed">27065789</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi Y., Ohkubo T., Kawaji H., Machida A., Miyata H., Goda S., Roy S., Hayashizaki Y., Suzuki H., Yokota T. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes. Neurosci. Lett. 2016;636:48&#x2013;57. doi: 10.1016/j.neulet.2016.10.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.10.042</ArticleId><ArticleId IdType="pubmed">27780738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey T.J., Steyn F.J., Wolvetang E.J., Ngo S.T. Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease. Front. Mol. Neurosci. 2018;11:10. doi: 10.3389/fnmol.2018.00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00010</ArticleId><ArticleId IdType="pmc">PMC5787076</ArticleId><ArticleId IdType="pubmed">29410613</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-H., Tsai L.-K., Liao K.-Y., Wu T.-C., Huang Y.-H., Huang Y.-C., Chang S.-W., Wang P.-Y., Tsao Y.-P., Chen S.-L. Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction. J. Cachex Sarcopenia Muscle. 2018;9:771&#x2013;785. doi: 10.1002/jcsm.12299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12299</ArticleId><ArticleId IdType="pmc">PMC6104115</ArticleId><ArticleId IdType="pubmed">29608040</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller T., Braud S., J&#xfc;ttner R., Voigt B.C., Paulick K., Sheean M.E., Klisch C., Guneykaya D., Rathjen F.G., Geiger J.R., et al. Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons. EMBO J. 2018;37:e98858. doi: 10.15252/embj.201798858.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798858</ArticleId><ArticleId IdType="pmc">PMC6120667</ArticleId><ArticleId IdType="pubmed">30049711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimkhani S., Vafaee F., Young P.E., Hur S.S.J., Hawke S., Devenney E., Beadnall H., Barnett M.H., Suter C.M., Buckland M.E. Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci. Rep. 2017;7:14293. doi: 10.1038/s41598-017-14301-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14301-3</ArticleId><ArticleId IdType="pmc">PMC5662562</ArticleId><ArticleId IdType="pubmed">29084979</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., van der Spek R.A.A., Bakker M.K., van Vugt J.J.F.A., Hop P.J., Zwamborn R.A.J., de Klein N., Westra H.-J., Bakker O.B., Deelen P., et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 2021;53:1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Crippa V., Cereda C., Bonetto V., Zucchi E., Gessani A., Ceroni M., Chio A., D&#x2019;Amico R., Monsurr&#xf2; M.R., et al. Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) BMJ Open. 2019;9:e028486. doi: 10.1136/bmjopen-2018-028486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028486</ArticleId><ArticleId IdType="pmc">PMC6549675</ArticleId><ArticleId IdType="pubmed">31152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A., Croixmarie V., Bouscary A., Mosbach A., Keime C., Boursier-Neyret C., Walter B., Spedding M., Loeffler J.-P. Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018;10:433. doi: 10.3389/fnmol.2017.00433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00433</ArticleId><ArticleId IdType="pmc">PMC5758557</ArticleId><ArticleId IdType="pubmed">29354030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S., Noyce A.J., Hemani G., Nicolas A., Calvo A., Mora G., Arosio A., Barberis M., Bartolomei I., Battistini S., et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 2019;85:470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Poehler A.-M., Xiang W., Spitzer P., May V.E.L., Meixner H., Rockenstein E., Chutna O., Outeiro T.F., Winkler J., Masliah E., et al. Autophagy modulates SNCA/&#x3b1;-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014;10:2171&#x2013;2192. doi: 10.4161/auto.36436.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.36436</ArticleId><ArticleId IdType="pmc">PMC4502760</ArticleId><ArticleId IdType="pubmed">25484190</ArticleId></ArticleIdList></Reference><Reference><Citation>Minakaki G., Menges S., Kittel A., Emmanouilidou E., Schaeffner I., Barkovits K., Bergmann A., Rockenstein E., Adame A., Marxreiter F., et al. Autophagy inhibition promotes SNCA/alpha&#x3b1;-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14:98&#x2013;119. doi: 10.1080/15548627.2017.1395992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1395992</ArticleId><ArticleId IdType="pmc">PMC5846507</ArticleId><ArticleId IdType="pubmed">29198173</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda A.M., Di Paolo G. Endolysosomal dysfunction and exosome secretion: Implications for neurodegenerative disorders. Cell Stress. 2018;2:115&#x2013;118. doi: 10.15698/cst2018.05.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2018.05.136</ArticleId><ArticleId IdType="pmc">PMC6551703</ArticleId><ArticleId IdType="pubmed">31225476</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratta S., Tancini B., Sagini K., Delo F., Chiaradia E., Urbanelli L., Emiliani C. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic and Endo-Lysosomal Systems Go Extracellular. Int. J. Mol. Sci. 2020;21:2576. doi: 10.3390/ijms21072576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072576</ArticleId><ArticleId IdType="pmc">PMC7178086</ArticleId><ArticleId IdType="pubmed">32276321</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X., Wang Y., Zheng J.C. Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases. Transl. Neurodegener. 2022;11:53. doi: 10.1186/s40035-022-00330-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00330-0</ArticleId><ArticleId IdType="pmc">PMC9743667</ArticleId><ArticleId IdType="pubmed">36510311</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>